Visiting Brigham and Women’s Hospital
It was a privilege for Lara Zibners, Co-Founder & Chairman, and I to meet with senior leadership of Brigham and Women’s Hospital in Boston led by Chief of the Division of Women’s Health Dr Kathryn Rexrode, Dr Raina Fichorova Chair in OBGYN / Vice Chair for Research, Sandra J. Butler, MPH Director of Design Impact, Dr Hadine …
Dr. Arturo Jose Mendoza Meinhardt Joins as Senior Scientist
Welcome to Arturo Jose Mendoza Meinhardt, PhD who joins our team as a Senior Scientist. Arturo is a biomaterials scientist and engineer with expertise in medical device development, analytical characterisation, and drug delivery formulations (including 18 months prior experience with our Callavid technology working as a consultant). We’re delighted to have you on-board!
Presenting at the Femtech & Consumer Innovation Summit – New Jersey
Having easily had a thousand rejections (and counting) – but at the same time with some success including $5m+ in grants / non-dilutive funding – raising funding in the women’s health space is *NOT for the faint of heart* (and no matter how important and impactful an innovation is) 😳. I’m looking forward to sharing some …
Welcoming Dr. Janet Halliday to Calla Lily Clinical Care’s New Labs and Offices
Our CMC (Chemistry, Manufacturing and Controls) Advisor Dr Janet Halliday had her first visit to Calla Lily Clinical Care’s new labs and offices. It was particularly inspiring for members of our team to hear about Janet’s journey and decades of vaginal drug delivery knowledge, starting as a formulation scientist for a university spinoff and progressing to the …
Dr. Elham Shirani Joins as Biomedical Engineer
Welcome to Elham Shirani, PhD who joins our team as a Biomedical Engineer. Elham is a recent PhD graduate from Macquarie University, where she brings her passion for FemTech and expertise in surface engineering & polymeric membrane/material modification to our vaginal drug delivery platform. We’re delighted to have you on-board!
Attending the FemTech Forward 2024 Conference
Team members Thang Vo-Ta and Kaylie Mings represented Calla Lily at the FemTech Conference held at University of Oxford. Besides Thang’s presentation on the progress of our Callavid drug delivery & Lilyvid sample collection technologies, there were also more personal sharings with the wider community at an innovation showcase held in the observatory building of …
Attending the Endometriosis Foundation of America Annual Blossom Ball
Our co-founder Dr. Lara Zibners was in New York to attend the Endometriosis Foundation of America Annual Blossom Ball. The exciting and impactful annual event included an important award to Drs Christine Metz and Peter K. Gregersen from The Feinstein Institutes Northwell Health for their ground breaking work in diagnosing endometriosis. A big congratulations to …
Sabrina Franco Joins as Product Development Engineer
Welcome to Sabrina Franco who joins our team as a Product Development Engineer. As a recent graduate from Imperial College London and Boston University, she brings a passion for impactful solutions for womens health. We’re delighted to have you on-board!
Attending the Women’s Health Innovation Summit Europe
As is always the case with the Women’s Health Innovation Series Summits, it was an invigorating and inspiring 2 days in Basel. Besides making new connections with small & large change-makers advancing womens health – it was also great to catch-up with existing collaborators: Brandi Howard, from Premier Research our regulatory/clinical trial advisors. Professor Joyce …
Attending the Inaugral Microbes in Women’s Health Congress
Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space. The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …